Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 210 results found. Search for [ Lupin share ]

Results 1 to 21 of 210
BusinessToday.In
New Delhi, November 12, 2019
The deal proceeds will be utilised to strengthen Lupin's balance sheet as well as provide growth capital to support organic and inorganic initiatives for our focus markets, says Lupin CEO Vinita Gupta


BusinessToday.In
New Delhi, November 12, 2019
Benchmark indices Sensex and Nifty ended marginally higher (0.04 per cent) on Monday on weak global equities amid diminishing US-China trade deal hopes


BusinessToday.In
November 11, 2019
Amara Raja's stock opened with a gain of 3.36% today and later jumped 11.58% to touch the intraday high of Rs 729.75 on the BSE


BusinessToday.In
November 11, 2019
The 'Advertising & Media' sector firm also reported a healthy  evenue from operations that surged 40.4% to Rs 84.7 crore as against Rs 60.3 crore in the same quarter last year


PTI
November 11, 2019
At the interbank foreign exchange, the rupee opened at 71.36 against the US dollar, showing a decline of 8 paise over its previous closing


PTI
November 8, 2019
Revenue from operations stood at Rs 4,007.63 crore as against Rs 3,946.77 crore in the same period a year ago, a growth of 1.57 per cent


BusinessToday.In
November 8, 2019
The share purchase by Jhunjhunwala comes at a time when YES Bank finds itself on a sticky wicket in terms of its financial position


BusinessToday.In
New Delhi, November 7, 2019
HPCL Q2 results: Total income in July-September dipped 9.40 per cent to Rs 66,850.89 crore against Rs 73,789.50 crore in Q2FY19


PB Jayakumar
New Delhi, November 7, 2019
Lupin's net sales for the quarter stood at Rs 4,296 crore, an increase of 10.4 per cent compared to Rs 3,890 crore in the Q2FY19. The company posted a net loss of Rs 127 crore (after exceptional items) in Q2FY20, compared to Rs 266 crore net profit during the same quarter of the previous year


BusinessToday.In
New Delhi, November 6, 2019
Lupin Q2 results: Consolidated revenue from operations of the pharma major increased 10.3 per cent year-on-year (YoY) to Rs 4,359.7 crore in Q2FY20 as against Rs 3,951 crore in Q2FY19


PTI
October 7, 2019



BusinessToday.In
New Delhi, October 7, 2019
Weighed down by USFDA observations, share price of Aurobindo Pharma declined as much as 20.65 per cent to hit a 52-week low of Rs 450 on the BSE, after opening tad lower at Rs 560 against previous close level of Rs 567.15 on the BSE


PTI
October 7, 2019



E Kumar Sharma
September 5, 2019
Even as smaller Indian companies are looking to grow their business in the US market, the larger focus is on leading pharma companies because the top 20 of them contribute 75 per cent to total pharma exports from India


PTI
August 7, 2019
Drug firm Lupin on Wednesday reported a 49.46 per cent rise in consolidated net profit to Rs 303.05 crore for the quarter ended June 30, 2019 on account of robust sales in India and overseas.


BusinessToday.In
June 7, 2019
Share Market Update: Domestic equity benchmark indices closed marginally higher, after a volatile trading session today.


BusinessToday.In
May 27, 2019
Lupin share price fell declined 5.43 per cent to Rs 721.50 on the BSE. On the NSE, shares dropped 5.67 per cent to Rs 720. Lupin share price opened at a loss of 2.48% at 744 in trade today compared to the previous close of 762.95 on BSE.


PTI
May 17, 2019
Revenue for the quarter under discussion was up by 14 per cent at Rs 4,016.60 crore against Rs 3,534.90 crore in the same quarter last fiscal, the city-based drug-maker said in a press release.


E Kumar Sharma
New Delhi, May 16, 2019
Some of the generic companies, it points out, made unsolicited bids to customers of bigger players in cases where drug prices were high as a way to compete with a bigger generic player to grab a bigger share in the market. Interestingly, this exercise seems to have elements of attempts at trying to drive down prices to gain customers.


BusinessToday.In
New Delhi, May 15, 2019
Net profit after exceptional items was up 141.4 per cent at Rs 606.60 crore during the financial year ended March 31, 2019; sales for Q4 FY2019 were up 8.7 per cent at Rs 4,325.90 crore compared to Rs 3,978.50 crore in Q4 FY2018;


PAGES 1 OF 11  12345